CYGN-2278

N/A

Report date: 2025/01/26 18:21:55
NME

Base Information

Drug NameCYGN-2278
Drug Alias NameGrk2 inhibitor (cygnal/Inzen/MOMA/Fog Pharma/Affinivax/Vertex/Juvenescenc/Bristol Myers Squibb)Grk2 inhibitor (cygnal/Inzen/MOMA/Fog Pharma/GSK/Vertex/Juvenescenc/Bristol Myers Squibb)CYGN-2278
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-adrenergic receptor kinase 1 inhibitors
TargetsBeta-adrenergic receptor kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSonata Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCygnal TherapeuticsJuvenescence LtdParabilis Medicines Inc +[7] 
Inactive CompaniesAffinivax Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A